Speaker illustration

Doctor Takahiro Kambara

Nagoya University Graduate School of Medicine, Seto (Japan)

Member of:

European Society of Cardiology

Additional use of SGLT2 inhibitors in the treatment of acute decompensated heart failure may prevent acute kidney injury

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: New aspects of heart failure treatment


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb